Company: SCLXW
Filing Date: 2025-12-29
Form Type: 424B3
Source: 0001193125-25-335429
Chunk: 615

Company: Scilex Holding Co
Filing Date: 2025-12-29
Form: 424B3
Chunk 615
---
 Stock equals
or exceeds $630.00 per share for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders, the Company may
redeem all the Public Warrants at a price of $0.01 per warrant upon not less than 30 days’ prior written notice.

F-92

If the Company calls the Public Warrants for redemption, the Company will have the option to require all
holders that wish to exercise the Public Warrants to do so on a cashless basis. The Company will not be required to net cash settle the SPAC Warrants.

The Public Warrants are equity-classified warrants and recognized in additional paid-in capital in the accompanying
consolidated balance sheets. The Private Warrants are liability-classified warrants and are recognized as liabilities (refer to Notes 1 and 4).

During
the year ended December 31, 2023, the SPAC Warrants held by Sorrento were repurchased, and certain of such warrants transferred to Oramed, as a result of the Sorrento SPA (refer to Note 8). On September 20, 2024, the Company repurchased
4,000,000 of the SPAC Warrants (which are currently exercisable for an aggregate of up to 114,286 shares of Common Stock) held by Oramed (refer to Note 7). Following the repurchase, these warrants were cancelled.

As of September 30, 2025 and December 31, 2024, there were Public Warrants exercisable for an aggregate of up to 156,115 and
156,220 shares of Common Stock outstanding, respectively.

As of each of September 30, 2025 and December 31, 2024, there were
1,000,000 Private Warrants outstanding, which are currently exercisable for an aggregate of up to 28,572 shares of Common Stock.

Preferred Stock

The Company is authorized to
issue 45,000,000 shares of preferred stock (the “Preferred Stock”) of which there are two series in total.

Series A Preferred Stock

As of September 30, 2025 and December 31, 2024, there were 29,057,097 shares of Series A Preferred Stock outstanding. On September 21,
2023, the Series A Preferred Stock was repurchased and derecognized for accounting purposes. The Series A Preferred Stock is